Table 2.

Tumour location and disease stage

	Pre-pandemic period, n (%) N = 278	COVID-19 period, n (%) N = 340	p-value
Larynx/hypopharynx	89 (32)	113 (33.2)	0.845
Oral cavity	126 (45.3)	109 (32.1)	0.010
Oropharynx	39 (14)	64 (18.8)	0.174
Salivary glands	8 (2.9)	12 (3.5)	0.829
CUP	7 (2.5)	18 (5.3)	0.128
Nasal cavity/sinuses	8 (2.9)	13 (3.8)	0.683
Nasopharynx	1 (0.4)	11 (3.2)	0.017
Locally advanced disease (T1–T2)	150 (54)	181 (53.2)	0.858
Regional disease (N+)	143 (51.4)	189 (55.6)	0.303
Advanced stage (III/IV)	187 (67.5)	247 (72.6)	0.165

CUP – carcinoma of unknown primary